OpenURL Connection Search

Select item for more details and to access through your institution.

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.
Published in:
Eurosurveillance (15607917), 2024, v. 29, n. 1, p. 6, doi. 10.2807/1560-7917.ES.2024.29.1.2300670
By:
- Fontán-Vela, Mario;
- Kissling, Esther;
- Nicolay, Nathalie;
- Braeye, Toon;
- Van Evercooren, Izaak;
- Hansen, Christian Holm;
- Emborg, Hanne-Dorthe;
- Fabiani, Massimo;
- Mateo-Urdiales, Alberto;
- AlKerwi, Ala’a;
- Schmitz, Susanne;
- Castilla, Jesús;
- MartínezBaz, Iván;
- de Gier, Brechje;
- Hahné, Susan;
- Meijerink, Hinta;
- Starrfelt, Jostein;
- Nunes, Baltazar;
- Caetano, Constantino;
- Derrough, Tarik
Publication type:
Article
Effectiveness of XBB.1.5 Monovalent COVID‐19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS‐EHR Network Study.
Published in:
Influenza & Other Respiratory Viruses, 2024, v. 18, n. 4, p. 1, doi. 10.1111/irv.13292
By:
- Monge, Susana;
- Humphreys, James;
- Nicolay, Nathalie;
- Braeye, Toon;
- Van Evercooren, Izaak;
- Holm Hansen, Christian;
- Emborg, Hanne‐Dorthe;
- Sacco, Chiara;
- Mateo‐Urdiales, Alberto;
- Castilla, Jesús;
- Martínez‐Baz, Iván;
- de Gier, Brechje;
- Hahné, Susan;
- Meijerink, Hinta;
- Kristoffersen, Anja Bråthen;
- Machado, Ausenda;
- Soares, Patricia;
- Nardone, Anthony;
- Bacci, Sabrina;
- Kissling, Esther
Publication type:
Article
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium.
Published in:
BMC Research Notes, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13104-023-06608-4
By:
- Vermeiren, Elias;
- van Loenhout, Joris A. F.;
- Nasiadka, Léonore;
- Stouten, Veerle;
- Billuart, Matthieu;
- Van Evercooren, Izaak;
- Catteau, Lucy;
- Hubin, Pierre
Publication type:
Article
Monitoring COVID‐19 vaccine effectiveness against COVID‐19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Published in:
Influenza & Other Respiratory Viruses, 2023, v. 17, n. 11, p. 1, doi. 10.1111/irv.13195
By:
- Kislaya, Irina;
- Sentís, Alexis;
- Starrfelt, Jostein;
- Nunes, Baltazar;
- Martínez‐Baz, Iván;
- Nielsen, Katrine Finderup;
- AlKerwi, Ala'a;
- Braeye, Toon;
- Fontán‐Vela, Mario;
- Bacci, Sabrina;
- Meijerink, Hinta;
- Castilla, Jesús;
- Emborg, Hanne‐Dorthe;
- Hansen, Christian Holm;
- Schmitz, Susanne;
- Van Evercooren, Izaak;
- Valenciano, Marta;
- Nardone, Anthony;
- Nicolay, Nathalie;
- Monge, Susana
Publication type:
Article

Found: 4

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023.

Effectiveness of XBB.1.5 Monovalent COVID‐19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS‐EHR Network Study.

Factors underlying COVID-19 booster vaccine uptake among adults in Belgium.

Monitoring COVID‐19 vaccine effectiveness against COVID‐19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.